EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa

2019 ◽  
Vol 182 (3) ◽  
pp. 794-797 ◽  
Author(s):  
S. Gaucher ◽  
S.M. Lwin ◽  
M. Titeux ◽  
A. Abdul‐Wahab ◽  
N. Pironon ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Phase I ◽  
Epidermolysis Bullosa ◽  
Ex Vivo ◽  
Dystrophic Epidermolysis Bullosa ◽  
Gene Therapy Trial ◽  
Recessive Dystrophic Epidermolysis Bullosa ◽  
Therapy Trial

scholarly journals SIN Retroviral Vectors Expressing COL7A1 Under Human Promoters for Ex Vivo Gene Therapy of Recessive Dystrophic Epidermolysis Bullosa

2010 ◽  
Vol 18 (8) ◽  
pp. 1509-1518 ◽  
Author(s):  
Matthias Titeux ◽  
Valérie Pendaries ◽  
Maria A Zanta-Boussif ◽  
Audrey Décha ◽  
Nathalie Pironon ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Epidermolysis Bullosa ◽  
Ex Vivo ◽  
Retroviral Vectors ◽  
Dystrophic Epidermolysis Bullosa ◽  
Ex Vivo Gene Therapy ◽  
Recessive Dystrophic Epidermolysis Bullosa
Sign in / Sign up

Export Citation Format

Share Document